不同剂量瑞芬太尼对全麻患者丙泊酚靶控输注诱导剂量及时间的影响

陆松虹; 徐晖; 潘松; 张景俊; 李勇

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

不同剂量瑞芬太尼对全麻患者丙泊酚靶控输注诱导剂量及时间的影响

陆松虹 , 徐晖 , 潘松 , 张景俊 , 李勇

文章导航 > 蚌埠医学院学报 > 2012, 36 > 3: (277-279)

引用本文:

Citation:

不同剂量瑞芬太尼对全麻患者丙泊酚靶控输注诱导剂量及时间的影响

1.
安徽省蚌埠市第三人民医院麻醉科,233000

作者简介: 陆松虹(1970-)，女，副主任医师

通讯作者: 徐晖;

基金项目:
蚌埠市科技计划项目2009-68

The effects of different dosages of remifentanil on time and dose with propofol target controlled infusion on general anesthesia patients

1.
Department of Anesthesiology, Bengbu Third People′s Hospital, Bengbu 233000

Corresponding author: XUI Hui

摘要: 目的：观察不同剂量瑞芬太尼持续静脉输注对丙泊酚靶控输注诱导剂量及时间的影响。方法：40例全麻患者随机分为4组，丙泊酚初始靶控输注剂量设为1.5 mg/L，每4 min增加0.5 mg/L，待改良警觉镇静评分(MOAA/S)为1分时，Ⅰ组输注生理盐水，为对照组；Ⅱ、Ⅲ、Ⅳ组持续静脉输注瑞芬太尼，剂量分别为0.1、0.2和0.4gkg-1min-1；在MOAA/S为0分时给予阿曲库铵0.6 mg/kg，3 min后行气管插管。记录瑞芬太尼输注时间及插管时丙泊酚的总量。同时观察诱导期间低血压、心动过缓及呼吸抑制等不良反应。结果：Ⅰ组丙泊酚用量均高于Ⅱ组、Ⅲ组和Ⅳ组(P；0.05～P；0.01)，Ⅱ组用量高于Ⅲ组和Ⅳ组(P；0.01和P；0.05)，Ⅲ组和Ⅳ组用量差异无统计学意义(P；0.05)；Ⅰ组瑞芬太尼输注时间与Ⅱ组差异无统计学意义(P；0.05)；Ⅰ组与Ⅲ组和Ⅳ组差异均有统计学意义(P；0.01)，Ⅱ组与Ⅲ组、Ⅳ组差异亦有统计学意义(P；0.01)，Ⅲ组与Ⅳ组差异有统计学意义(P；0.05)。4组不良反应的发生率有统计学意义(P；0.01)。结论：不同剂量瑞芬太尼可以缩短丙泊酚靶控输注麻醉诱导的时间，减少丙泊酚用量；丙泊酚靶控输注复合瑞芬太尼0.2gkg-1min-1持续静脉输注即可满足临床需求。
- 瑞芬太尼 /
- 丙泊酚 /
- 靶控输注 /
- 持续输注
Abstract: Objective:To investigate the effects of different dosages of remifentanil on dose and time in propofol target controlled infusion(TCI) induction.Methods:Forty patients,classified as ASAⅠ-Ⅱ,undergoing general anesthesia were randomly divided into four groups:group Ⅰ,group Ⅱ,group Ⅲ and group Ⅳ.Anesthesia was induced with propofol target controlled infusion,the target plasma concentration of propofol was started with 1.5 mg/L,and increased 0.5 mg/L every four minutes.When patients lose response,the patients received remifentanil infusion,the dosage was set at 0.1,0.2,and 0.4 gkg-1min-1 in group Ⅱ,group Ⅲ and group Ⅳ,respectively.The group Ⅰ as a controll received normal saline.When modified obsever is assessment of alertness/sedation scale is zero,0.6 mg/kg tracrium was given to facilitated tracheal intubation after 3 min.The infusion time of remifentanil and total dose of propofol were recorded.The adverse effects such as hypotension,bradycardia and respiratory depression were recorded during induction.Results:The propofol dosages in group Ⅰ were higher than those in group Ⅱ,group Ⅲ and group Ⅳ(P0.05-P0.01).The propofol dosages in groupⅡ were higher than those in group Ⅲ and group Ⅳ(P0.01 and P0.05);There was no significant difference between groupⅢ and group Ⅳ(P0.05).The infusion time of groupⅠ was not significant different with group Ⅱ(P0.05),but there were significant differences with group Ⅲ and group Ⅳ(P0.01).In contrast to Group Ⅱ,there were differences with group Ⅲ and group Ⅳ(P0.01);and differences between group Ⅲ and group Ⅳ(P0.05).The accidence of adverse effects had significant differences(P0.01).Conclusions:Different doses of remifentanil can reduce the infusion time of propofol TCI,reduce the dose of propofol;propofol TCI induction combined with 0.2 gkg-1min-1 remifentanil infusion can meet the clinical needs.
- remifentanil /
- propofol /
- target controlled infusion /
- continuous infusion

[2] Victor C,Gilles G,Gilles G,et al.Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement[J].Anesth Analg,2003,96(1):33-38.
[2]	Miller RD.米勒麻醉学[M].北京:北京大学医学出版社,2006:396.
[3] Milne ST,Kenny GN,Schraag S.Propofol sparing effect of remifentanil using close-loop Anaesthsia[J].Br J Anesth,2003,90(5):623-629.
[4] 曹建方,谢红,李华,等.瑞芬太尼复合丙泊酚靶控输注在气管插管中的应用[J].临床麻醉学杂志,2010,26(7):629-630.
[5] 耿志宇,许幸,吴新民.瑞芬太尼复合异丙酚靶控输注诱导时的量效关系[J].中华麻醉学杂志,2004,24(4):260-263.
[6] Egan TD,Lemmens HJ,Fiset P,et al.The pharmacokinetics of the new short acting opioid remifenyanil(GI87084B) in healty adult male volunteers[J].Anesthesiology,1993,79(5):881-892.
[7] 王玲英,汪芳俊,杨小霖.不同剂量瑞芬太尼对气管插管反应的影响[J].临床麻醉学杂志,2008,24(6):484-486.
[8] 王文娟,丁正年,谢红,等.瑞芬太尼对老年患者气管插管心血管反应的影响[J].临床麻醉学杂志,2010,26(6):471-473.

[1]	郭全周 . 地佐辛与芬太尼联合靶控输注丙泊酚用于无痛ERCP的对比研究. 蚌埠医学院学报, 2014, 39(11): 1538-1539.
[2]	张景俊 , 徐晖 , 程亮 , 潘松 , 吴鸿浩 . 雷米芬太尼对丙泊酚靶控输注诱导期间效应室浓度及麻醉深度的影响. 蚌埠医学院学报, 2014, 39(12): 1671-1673.
[3]	李晓立 , 李晓红 , 文公堂 , 王南海 , 金钟 . 靶控输注丙泊酚与联合瑞芬太尼用于无痛人工流产术的临床效果比较. 蚌埠医学院学报, 2008, 33(4): 405-408.
[4]	彭晓东 , 吴庆玲 , 郑立东 , 李家宽 . Narcotrend分级指导下丙泊酚靶控输注用于高血压患者麻醉的临床观察. 蚌埠医学院学报, 2015, 40(4): 467-469. doi: 10.13898/j.cnki.issn.1000-2200.2015.04.016
[5]	李华忠 , 徐继海 , 宋际明 , 袁管京 , 黄忠义 . 丙泊酚与瑞芬太尼靶控输注对腹腔镜胆囊切除术的麻醉效果及病人术后认识功能的作用. 蚌埠医学院学报, 2018, 43(7): 904-906,911. doi: 10.13898/j.cnki.issn.1000-2200.2018.07.017
[6]	吴宣 , 沈勤 , 肖建军 . 靶控输注瑞芬太尼对全麻苏醒期心血管反应的影响. 蚌埠医学院学报, 2015, 40(4): 464-466. doi: 10.13898/j.cnki.issn.1000-2200.2015.04.015
[7]	吴年生 , 汪东学 , 王玲 . 右美托咪定联合瑞芬太尼和丙泊酚泵注对甲状腺术中神经电生理监测的影响. 蚌埠医学院学报, 2020, 45(2): 207-210. doi: 10.13898/j.cnki.issn.1000-2200.2020.02.019
[8]	梁启胜 , 杨茗竣 , 符炜 , 凌云志 . 脑电双频指数指导下丙泊酚、舒芬太尼联合靶控对冠状动脉旁路移植术麻醉诱导期血流动力学影响. 蚌埠医学院学报, 2012, 36(10): 1155-1158.
[9]	李克寒 , 杨惠敏 , 郭丹 . 瑞芬太尼或不同剂量地佐辛全麻诱导期喉罩置入对丙泊酚半数有效血浆靶浓度的影响. 蚌埠医学院学报, 2016, 41(10): 1299-1301,1305. doi: 10.13898/j.cnki.issn.1000-2200.2016.10.013
[10]	郑立东 , 杨松宝 , 李家宽 . 依托咪酯乳剂复合舒芬太尼持续泵注在腹腔镜胆囊切除术中的应用. 蚌埠医学院学报, 2010, 35(11): 1116-1118.
[11]	陈龙 , 张茂银 , 耿兴云 . 丙泊酚靶控复合吸入低浓度异氟烷在小儿短小手术中的应用. 蚌埠医学院学报, 2007, 32(6): 720-722.
[12]	赵琛 , 李应杰 . 瑞芬太尼复合丙泊酚在无痛胃镜检查中的应用. 蚌埠医学院学报, 2014, 39(8): 1080-1081.
[13]	张桥 . 丙泊酚复合瑞芬太尼静脉麻醉用于支撑喉镜下声带息肉切除术. 蚌埠医学院学报, 2013, 37(4): 449-450,454.
[14]	张静 , 詹春光 , 陈永亮 . 瑞芬太尼联合丙泊酚用于控制性降压对胃黏膜内pH值的影响. 蚌埠医学院学报, 2008, 33(5): 548-551.
[15]	葛春林 . 硬膜外麻醉下丙泊酚靶控输注镇静在老年患者中的应用. 蚌埠医学院学报, 2007, 32(3): 303-305.
[16]	凌云志 , 梁启胜 , 李晓红 , 禹莉 . 靶控输注咪达唑仑对硬膜外麻醉寒战的影响. 蚌埠医学院学报, 2010, 35(8): 776-778,781.
[17]	吴丽莉 , 季磊 , 陈素娥 . 顺式阿曲库铵闭环靶控输注与持续输注对胆囊切除术病人MAP、HR、SpO₂及肌松药物用量的影响. 蚌埠医学院学报, 2022, 47(9): 1233-1236. doi: 10.13898/j.cnki.issn.1000-2200.2022.09.020
[18]	陈仁军 , 胡春涛 , 袁力勇 , 刘功俭 . 静脉预注硫酸镁抑制丙泊酚注射痛的临床研究. 蚌埠医学院学报, 2012, 36(1): 29-32.
[19]	陈强 , 徐志云 , 石伯生 , 黄丽 . 瑞芬太尼泵注全麻用于儿童扁桃体切除术的临床观察. 蚌埠医学院学报, 2009, 34(3): 236-238.
[20]	周海 , 张腾云 , 吴娴 , 王建华 . 不同药物配伍用于小儿头颈部手术麻醉的效果比较. 蚌埠医学院学报, 2014, 38(1): 63-65.

点击查看大图

计量

文章访问数: 2589
HTML全文浏览量: 319
PDF下载量: 331
被引次数: 0

不同剂量瑞芬太尼对全麻患者丙泊酚靶控输注诱导剂量及时间的影响

通讯作者: 徐晖;

作者简介: 陆松虹(1970-)，女，副主任医师

1. 安徽省蚌埠市第三人民医院麻醉科,233000

收稿日期: 2011-05-08
网络出版日期: 2012-03-15

基金项目: 蚌埠市科技计划项目2009-68

关键词:

摘要: 目的：观察不同剂量瑞芬太尼持续静脉输注对丙泊酚靶控输注诱导剂量及时间的影响。方法：40例全麻患者随机分为4组，丙泊酚初始靶控输注剂量设为1.5 mg/L，每4 min增加0.5 mg/L，待改良警觉镇静评分(MOAA/S)为1分时，Ⅰ组输注生理盐水，为对照组；Ⅱ、Ⅲ、Ⅳ组持续静脉输注瑞芬太尼，剂量分别为0.1、0.2和0.4gkg-1min-1；在MOAA/S为0分时给予阿曲库铵0.6 mg/kg，3 min后行气管插管。记录瑞芬太尼输注时间及插管时丙泊酚的总量。同时观察诱导期间低血压、心动过缓及呼吸抑制等不良反应。结果：Ⅰ组丙泊酚用量均高于Ⅱ组、Ⅲ组和Ⅳ组(P；0.05～P；0.01)，Ⅱ组用量高于Ⅲ组和Ⅳ组(P；0.01和P；0.05)，Ⅲ组和Ⅳ组用量差异无统计学意义(P；0.05)；Ⅰ组瑞芬太尼输注时间与Ⅱ组差异无统计学意义(P；0.05)；Ⅰ组与Ⅲ组和Ⅳ组差异均有统计学意义(P；0.01)，Ⅱ组与Ⅲ组、Ⅳ组差异亦有统计学意义(P；0.01)，Ⅲ组与Ⅳ组差异有统计学意义(P；0.05)。4组不良反应的发生率有统计学意义(P；0.01)。结论：不同剂量瑞芬太尼可以缩短丙泊酚靶控输注麻醉诱导的时间，减少丙泊酚用量；丙泊酚靶控输注复合瑞芬太尼0.2gkg-1min-1持续静脉输注即可满足临床需求。

English Abstract

The effects of different dosages of remifentanil on time and dose with propofol target controlled infusion on general anesthesia patients

Corresponding author: XUI Hui

1. Department of Anesthesiology, Bengbu Third People′s Hospital, Bengbu 233000

Received Date: 2011-05-08
Available Online: 2012-03-15

Abstract: Objective:To investigate the effects of different dosages of remifentanil on dose and time in propofol target controlled infusion(TCI) induction.Methods:Forty patients,classified as ASAⅠ-Ⅱ,undergoing general anesthesia were randomly divided into four groups:group Ⅰ,group Ⅱ,group Ⅲ and group Ⅳ.Anesthesia was induced with propofol target controlled infusion,the target plasma concentration of propofol was started with 1.5 mg/L,and increased 0.5 mg/L every four minutes.When patients lose response,the patients received remifentanil infusion,the dosage was set at 0.1,0.2,and 0.4 gkg-1min-1 in group Ⅱ,group Ⅲ and group Ⅳ,respectively.The group Ⅰ as a controll received normal saline.When modified obsever is assessment of alertness/sedation scale is zero,0.6 mg/kg tracrium was given to facilitated tracheal intubation after 3 min.The infusion time of remifentanil and total dose of propofol were recorded.The adverse effects such as hypotension,bradycardia and respiratory depression were recorded during induction.Results:The propofol dosages in group Ⅰ were higher than those in group Ⅱ,group Ⅲ and group Ⅳ(P0.05-P0.01).The propofol dosages in groupⅡ were higher than those in group Ⅲ and group Ⅳ(P0.01 and P0.05);There was no significant difference between groupⅢ and group Ⅳ(P0.05).The infusion time of groupⅠ was not significant different with group Ⅱ(P0.05),but there were significant differences with group Ⅲ and group Ⅳ(P0.01).In contrast to Group Ⅱ,there were differences with group Ⅲ and group Ⅳ(P0.01);and differences between group Ⅲ and group Ⅳ(P0.05).The accidence of adverse effects had significant differences(P0.01).Conclusions:Different doses of remifentanil can reduce the infusion time of propofol TCI,reduce the dose of propofol;propofol TCI induction combined with 0.2 gkg-1min-1 remifentanil infusion can meet the clinical needs.